The Oncology Institute Inc (TOI)
0.61
-0.03
(-4.54%)
USD |
NASDAQ |
May 20, 16:00
0.6284
+0.02
(+3.02%)
Pre-Market: 20:00
Oncology Institute Revenue (Quarterly): 94.67M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 94.67M |
December 31, 2023 | 85.79M |
September 30, 2023 | 82.04M |
June 30, 2023 | 80.22M |
March 31, 2023 | 76.19M |
December 31, 2022 | 71.42M |
September 30, 2022 | 64.98M |
June 30, 2022 | 60.92M |
March 31, 2022 | 55.16M |
Date | Value |
---|---|
December 31, 2021 | 52.30M |
September 30, 2021 | 52.28M |
June 30, 2021 | 49.84M |
March 31, 2021 | 48.58M |
December 31, 2020 | 187.52M |
September 30, 2020 | |
June 30, 2020 | 47.28M |
December 31, 2018 | 37.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
47.28M
Minimum
Jun 2020
187.52M
Maximum
Dec 2020
73.95M
Average
64.98M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
Encompass Health Corp | 1.316B |
Pediatrix Medical Group Inc | 495.10M |
US Physical Therapy Inc | 155.68M |
US Neurosurgical Holding Inc | -- |
American Oncology Network Inc | 364.34M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -19.89M |
Total Expenses (Quarterly) | 112.64M |
EPS Diluted (Quarterly) | -0.22 |
Enterprise Value | 67.96M |
Gross Profit Margin (Quarterly) | 12.64% |
Profit Margin (Quarterly) | -21.01% |
Earnings Yield | -132.8% |
Normalized Earnings Yield | -127.20 |